CooperVision® Canada Expands MiSight® 1 day Again to Treat Even More Children with Myopia
Full Expanded Range of -0.25 to -10.00D Makes Myopia Control a Possibility for More Canadian Children Than Ever Before
CooperVision Canada today announced that its MiSight® 1 day contact lenses will be available in higher prescriptions. The full expanded range—covering -0.25D to -10.00D (0.50D steps after -6.00D)— means that MiSight® 1 day covers 99.97% of prescriptions for age-appropriate children – who have myopia and less than 1D of astigmatism.[1] The diopter extension for this innovative, specially designed lens will allow even more children to benefit from myopia management.
MiSight® 1 day contact lenses are backed by the longest-running soft contact lens study among children. The clinical trial has proven that MiSight® 1 day works for nearly all children with myopia,[2]† cuts myopia progression by half,[3]§ works at any age a child starts treatment (8+),3║ works for as long as the child wears them3║ and data indicates that there is no rebound effect with MiSight® 1 day contact lenses.[4],[5]¶
With myopia on the rise globally,[6] an increasing number of children may require the higher prescriptions that MiSight® 1 day lenses will offer.
“Every diopter matters, particularly for children whose myopia progression may have already placed them at a higher risk for conditions such as myopic maculopathy and glaucoma.[7] While early treatment is best, it’s never too late to start,” said Enrique Contreras, Country Manager, CooperVision Canada, “Even older children starting with MiSight® 1 day have seen their myopia progression cut by half.”3§
As a global leader in myopia control* and management for children, CooperVision believes that options must be available for as many children as possible. With MiSight® 1 day’s additional range extension, eye care professionals in Canada can have even greater impact.
